Article
Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
International journal of antimicrobial agents - 1 May 2007
DiPersio Joseph R, Dowzicky Michael J
Abstract excerpt
We report here on the activity of tigecycline and comparators against multidrug-resistant (resistant to >or=3 antimicrobial classes; MDR) Enterobacteriaceae from the USA collected between January 2004 and January 2006 as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Nationally, 131 (5.9%) Escherichia coli, 174 (10.1%) Klebsiella pneumoniae, 4 (1.2%) Klebsiella oxytoca, 24 (4.9%) Enterobacter...
Topics
- Anti-Bacterial Agents
- Cephalosporin Resistance
- Drug Resistance, Multiple, Bacterial
- Enterobacteriaceae
- Enterobacteriaceae Infections
- Humans
- Microbial Sensitivity Tests
- Minocycline
- Phenotype
- Population Surveillance
- Quality Control
- Tigecycline
- United States
- beta-Lactamases